SHPH.F logo

Sihuan Pharmaceutical Holdings Group OTCPK:SHPH.F Stock Report

Last Price

US$0.045

Market Cap

US$679.7m

7D

0%

1Y

-52.6%

Updated

28 Mar, 2024

Data

Company Financials +

Sihuan Pharmaceutical Holdings Group Ltd.

OTCPK:SHPH.F Stock Report

Market Cap: US$679.7m

SHPH.F Stock Overview

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.

SHPH.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Sihuan Pharmaceutical Holdings Group Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sihuan Pharmaceutical Holdings Group
Historical stock prices
Current Share PriceHK$0.045
52 Week HighHK$0.12
52 Week LowHK$0.045
Beta0.70
1 Month Changen/a
3 Month Changen/a
1 Year Change-52.63%
3 Year Changen/a
5 Year Change-82.35%
Change since IPO-87.84%

Recent News & Updates

Recent updates

Shareholder Returns

SHPH.FUS PharmaceuticalsUS Market
7D0%2.2%0.2%
1Y-52.6%25.5%28.1%

Return vs Industry: SHPH.F underperformed the US Pharmaceuticals industry which returned 25.8% over the past year.

Return vs Market: SHPH.F underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is SHPH.F's price volatile compared to industry and market?
SHPH.F volatility
SHPH.F Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: SHPH.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SHPH.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20013,241Weicheng Guohttps://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing.

Sihuan Pharmaceutical Holdings Group Ltd. Fundamentals Summary

How do Sihuan Pharmaceutical Holdings Group's earnings and revenue compare to its market cap?
SHPH.F fundamental statistics
Market capUS$679.66m
Earnings (TTM)-US$282.47m
Revenue (TTM)US$245.31m

2.6x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SHPH.F income statement (TTM)
RevenueCN¥1.77b
Cost of RevenueCN¥541.07m
Gross ProfitCN¥1.23b
Other ExpensesCN¥3.27b
Earnings-CN¥2.04b

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.22
Gross Margin69.48%
Net Profit Margin-115.15%
Debt/Equity Ratio24.3%

How did SHPH.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.